Marvell Stock (MRVL)

Upside – $FOSL +23% (Q3 beat, gross margin surged and the FY sales and profit outlook was raised) – $SATL +21% (record Q3 revenue, positive adjusted EBITDA and a post-quarter deal to sell three in-orbit satellites for about $37M) – $RSKD +20% (Q3 revenue growth accelerated to 41% and revenue and adjusted EBITDA guidance was …

Upside – $VFC +4.0% (Piper Sandler and Truist upgrade as signs of Vans stabilization improve turnaround confidence) – $GS +3.0% (Q3 beat, led by surging equities revenue and stronger investment-banking fees) – $UNH +2.5% (Q3 beat and 2026 adjusted EPS outlook raised to at least $20.50) Downside – $SNDX -17.0% (MAXPIRe Phase 2 axatilimab trial …

Upside – $GIXI +135.0% (autonomous robots begin delivering blood and bone marrow at a major hospital, expanding an existing chemotherapy-logistics deployment) – $CCC +10.5% (GTCR and Elliott are reportedly in advanced acquisition talks, with a deal potentially coming this week) – $MEDS +7.0% (Humana adds the ChemoFx gynecologic-cancer assay to a Medicaid coverage policy) – …

Upside – $AEMD +403% (merger agreement with North Immunology adds an IL-13 x IL-18 bispecific-antibody program for atopic dermatitis) – $GNRC +30% (Amazon supply agreement includes $2.4B of backup-generator deliveries expected during 2027-2028) – $VEEA +30% (non-binding combination term sheet with NovaGen targets a $750M AI-health platform) – $DTSS +12% (strategic cooperation expands into AI-powered …

Housekeeping item. Into the afternoon swoon I have covered the basket of high-octane/beta shorts I recently put on. Some of the stocks in the basket include $MU, $AMAT, $SNDK, $AVGO, $MRVL and $TSM. As I have noted in the Comments Section, this strategy is not recommended for home gamers! Position: None